about
Type I interferonopathies in pediatric rheumatologyPowering the immune system: mitochondria in immune function and deficiencyEXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay.Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice.Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies.Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.A three-dimensional model of human lung development and disease from pluripotent stem cells.Deletion of WASp and N-WASp in B cells cripples the germinal center response and results in production of IgM autoantibodies.Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis.Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with wiskott-Aldrich syndromeType I interferon pathway activation in COPA syndrome.Type I interferon-mediated autoinflammation due to DNase II deficiency.CD70 Deficiency due to a Novel Mutation in a Patient with Severe Chronic EBV Infection Presenting As a Periodic Fever.Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection.Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.B cells characterization in ADA2 Deficiency patients.Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunityCirculating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case ReportPredisposition to infection and SIRS in mitochondrial disorders: 8 years' experience in an academic centerEfficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI SyndromeThe Danger Signal Extracellular ATP Is Involved in the Immunomediated Damage of α-Sarcoglycan-Deficient Muscular DystrophyRecent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
P50
Q26748746-D1EE89A7-5995-4C91-9F31-922B5AA51358Q26853485-3E07E2B3-3DF2-4A2C-A5C5-C0620CF936D2Q33112682-CF871573-0BE4-4BB7-A9E7-02227DFBFBDFQ33426239-2BAD7889-8080-4E35-9CCE-4A49831A4AD9Q33426736-2AC73013-7754-4B5B-8AA1-6F33C1D2C532Q35891625-8AC644C6-8CAB-4CEF-88FD-29F7F9D94C30Q38519892-BFD6CE63-30AC-418B-9885-11DABC739139Q39021414-92B1E62D-48BC-4F1E-B9AB-A427643A85C1Q40230465-53441C56-4B8C-4EAF-ABEB-DA14E7C4BC5FQ40768417-BA16F745-0B04-4F4D-9824-8353C3135BFAQ41224340-A571029F-BCC1-4C20-87BF-F7FD17C1118DQ42141807-86750F7D-86BB-4D1B-ADD2-F89599CBBCE8Q46298667-0FF14EEE-C215-4AD1-97CF-089EB63B46C2Q47108722-FBA9FB82-3715-4B08-8B54-A3DD7AF7C034Q50043168-7FCBCAF7-D5E8-41F0-A107-A3CD8BAF4E49Q50422132-0E77316F-1E93-4A7A-A8D7-4D719AE65DC2Q53515532-7E3D9E3E-6E35-4499-8100-855DDA48D7B8Q55121614-8CC2E108-93E1-4259-8B0E-4DF78B2B036DQ57133456-C3B5B531-BC4B-4917-A900-78C8D8204897Q58798950-8D559690-836A-403B-9097-6C05599CBF54Q63979798-9DFAE904-A232-4B55-9B9D-E65F195CDB3CQ92390237-B715039E-C9A6-4A93-8D12-B5EE437E4DD8Q93193810-032AE773-1EFE-4276-991D-68CDBFE20437Q95307017-3D108615-DDE5-45FA-AA56-E5F59E9BA7BF
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Stefano Volpi
@en
Stefano Volpi
@nl
type
label
Stefano Volpi
@en
Stefano Volpi
@nl
prefLabel
Stefano Volpi
@en
Stefano Volpi
@nl
P31
P496
0000-0002-7129-868X